Consensus CONMED Corporation

Equities

CNMD

US2074101013

Market Closed - Nyse Other stock markets 01:30:01 02/05/2024 am IST			5-day change	1st Jan Change
68.34 ^USD	+0.53%		-4.16%	-37.59%

25/04	Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	MT
25/04	Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	MT

Evolution of the average Target Price on CONMED Corporation

Price target over the last 5 years

History of analyst recommendation changes

aec274ac6c.SanCWIF3lSVYnmvYZnJx2q1Hw0vwsrUDvcl7ZIvKxzI.Fs2nAcUc1HwoqwWZLgE0nP8pgQnC29RAjoEwHdqbqwYA5pAq7kXYCD-vDA~872548549853e04fca6c6a6a8cb281e7

Analyst Recommendations on CONMED Corporation

Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	25/04	MT
Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	25/04	MT
Needham Adjusts Price Target on CONMED to $129 From $119, Maintains Buy Rating	01/02	MT
JPMorgan Cuts CONMED Price Target to $115 From $135, Maintains Overweight Rating	01/02	MT
Piper Sandler Adjusts Price Target on CONMED to $130 From $145, Maintains Overweight Rating	27/23/27	MT
Wells Fargo Cuts Price Target on CONMED to $107 From $123, Maintains Equalweight Rating	26/23/26	MT
Needham Adjusts Price Target on CONMED to $140 From $139, Maintains Buy Rating	27/23/27	MT
Keybanc Adjusts Price Target on CONMED to $141 From $131, Maintains Overweight Rating	27/23/27	MT
Needham Raises Price Target on CONMED to $139 From $135, Keeps Buy Rating	05/23/05	MT
CL King Starts CONMED at Buy With $140 Price Target	22/23/22	MT
Piper Sandler Raises CONMED's Price Target to $128 From $118, Maintains Overweight Rating	27/23/27	MT
Wells Fargo Adjusts Price Target on CONMED to $119 From $96, Maintains Equal-Weight Rating	27/23/27	MT
Needham Adjusts Price Target on CONMED to $135 From $122, Reiterates Buy Rating	27/23/27	MT
Keybanc Adjusts Price Target on CONMED to $131 From $124, Maintains Overweight Rating	27/23/27	MT
CONMED Upgraded by KeyBanc to Overweight From Sector Weight, Price Target Set at $124; Firm Sees Financial Profile Improving	27/23/27	MT
ANALYST RECOMMENDATIONS : Caterpillar, Conmed, Corning, Model N, United Rentals...	27/23/27
Needham Raises Price Target on CONMED to $122 From $106, Maintains Buy Rating	03/23/03	MT
Piper Sandler Adjusts CONMED's Price Target to $118 From $108, Maintains Overweight Rating	03/23/03	MT
Needham Cuts Price Target on CONMED to $90 From $123, Citing Currency Headwind, Inflation, Peer Multiple Contraction; Buy Rating Kept	14/22/14	MT
Jefferies Starts CONMED at Hold With $85 Price Target	12/22/12	MT
Needham Trims CONMED's Price Target to $123 From $127 on Near-Term Earnings Dilution From Biorez Deal; Buy Rating Kept	02/22/02	MT
Piper Sandler Adjusts CONMED's Price Target to $118 From $160, Reiterates Overweight Rating	28/22/28	MT
Needham Adjusts CONMED's Price Target to $127 From $155, Noting Currency Headwinds, Keeps Buy Rating Amid Accelerating Growth	28/22/28	MT
Stifel Nicolaus Adjusts Price Target for CONMED to $110 From $160, Maintains Buy Rating	23/22/23	MT
Needham Lifts CONMED's Price Target to $155 From $150 on In2Bones Acquisition, Reiterates Buy Rating	05/22/05	MT